Clinical trial
Docetaxel Followed by Surgery in Treating Women With Stage II or Stage III…
NCT00343512 · Vanderbilt-Ingram Cancer Center, Other · Terminated
Key facts
| NCT number | NCT00343512 |
|---|---|
| Title | Docetaxel Followed by Surgery in Treating Women With Stage II or Stage III Breast Cancer |
| Official title | Pilot Study of Neoadjuvant Dose Dense Docetaxel With Correlative Molecular Studies in Stage II/III Breast Cancer |
| Lead sponsor | Vanderbilt-Ingram Cancer Center, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Breast Cancer |
| Intervention type | Drug, Genetic, Other, Procedure |
| Interventions | docetaxel, protein expression analysis, laboratory biomarker analysis, biopsy, conventional surgery, neoadjuvant therapy |
| Enrollment | 34 |
| Start date | Feb 1, 2004 |
| Primary completion | Mar 1, 2008 |
| Completion | Mar 1, 2011 |
| First posted | Jun 23, 2006 |
| Last update posted | Apr 27, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: